Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report)’s stock price was down 8.3% during trading on Friday . The company traded as low as $14.25 and last traded at $14.25. Approximately 28,300 shares traded hands during trading, an increase of 418% from the average daily volume of 5,466 shares. The stock had previously closed at $15.54.
Shionogi & Co., Ltd. Stock Down 8.3%
The company has a fifty day moving average of $17.89 and a 200-day moving average of $16.61.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Read More
- Five stocks we like better than Shionogi & Co., Ltd.
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Do ETFs Pay Dividends? What You Need to Know
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- Technology Stocks Explained: Here’s What to Know About Tech
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
